20 LATEST RESOURCES (600 INDEXED)
Limited Usefulness of Neurocognitive Functioning Indices as Predictive Markers for Treatment Response to Methylphenidate or Neurofeedback@Home in Children and Adolescents with ADHD · January 2024
Articles
Frontiers in Psychiatry
The Use of Lisdexamfetamine to Treat ADHD in a Patient with Stimulant (Methamphetamine) Use Disorder · August 2023
Articles
Case Reports in Psychiatry
Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder · July 2023
Articles
CNS Drugs
Methylphenidate Is More Effective to Improve Inhibitory Control and Working Memory Compared to tDCS in Children and Adolescents with Attention Deficit/Hyperactivity Disorder: A Proof-of-Concept Study · July 2023
Articles
Frontiers in Neuroscience
Systematic Review of Suicidal Behaviors Related to Methylphenidate and Atomoxetine in Patients with Attention Deficit Hyperactivity Disorder · April 2023
Articles
Journal of the Korean Academy of Child and Adolescent Psychiatry
Perspectives of French Adolescents with ADHD and Child and Adolescent Psychiatrists Regarding Methylphenidate Use · March 2023
Articles
Scientific Reports
Case Report: Methylphenidate Improved Chronic Pain in an Adult Patient with Attention Deficit Hyperactivity Disorder · March 2023
Articles
Frontiers in Psychiatry
Effect of Methylphenidate on Functional Controllability: A Preliminary Study in Medication-Naive Children with ADHD · December 2022
Articles
Translational Psychiatry
Long-Term Methylphenidate Exposure and 24-Hours Blood Pressure and Left Ventricular Mass in Adolescents and Young Adults with Attention Deficit Hyperactivity Disorder · October 2022
Articles
European Neuropsychopharmacology
Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults with Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-Blind, Multicenter, Placebo-Controlled Trials · September 2022
Articles
Journal of Clinical Psychopharmacology
Risk of Major Cardiovascular and Cerebrovascular Events in Users of Lisdexamfetamine and Other Medications for Attention-Deficit/Hyperactivity Disorder in Denmark and Sweden: A Population-Based Cohort Study · August 2022
Articles
Neurology and Therapy
Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review · August 2022
Articles
Neurology and Therapy
Electrophysiological and Clinical Predictors of Methylphenidate, Guanfacine, and Combined Treatment Outcomes in Children with Attention-Deficit/Hyperactivity Disorder · August 2022
Articles
Journal of the American Academy of Child and Adolescent Psychiatry
Guanfacine for Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and/or Oppositional Defiance Disorder · July 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
OROS-Methylphenidate to Reduce ADHD Symptoms in Male Prisoners Aged 16-25 Years: A RCT · July 2022
Publications (Books-Reports)
National Institute for Health and Care Research
A Systematic Review of the Use of Atomoxetine for Management of Comorbid Anxiety Disorders in Children and Adolescents with Attention-Deficit Hyperactivity Disorder · June 2022
Articles
Research in Developmental Disabilities
Withdrawing Methylphenidate in Relation to Serum Levels of Ferritin and Zinc in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder · June 2022
Articles
Journal of Psychiatric Research